1-3 of 3
Tim Disher
Close
Sort by
Journal Articles

Systematic Literature Review and Meta-Analysis of Comparative Clinical Evidence Investigating Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) As First-Line Treatment for Transplant-Ineligible Newly Diagnosed Multiple Myeloma

Lucio Gordan, Rohan Medhekar, Alex Z. Fu, Abril Oliva Ramirez, Nicolle Bonar, Bao-Ngoc Nguyen, Michaela Spence, Rebecca McTavish, Tim Disher, Shuchita Kaila, Anjan J. Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1963.
https://doi.org/10.1182/blood-2023-180829
Published: 2023
Journal Articles

Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)

Clara Chen, Tim Disher, Muhaimen Siddiqui, Ignazia La Torre, Barry Skikne, MD, Beatrice Suero, Heather Cameron, Roya Gavanji, Chris Cameron
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-136625
Published: 2020
Journal Articles

Relationship between Vaso-Occlusive Crises and Important Complications in Sickle Cell Disease Patients

Miranda Bailey, Ajibola Abioye, George Morgan, Tom Burke, MSc, Tim Disher, Stephen Brown, Ashley Bonner, Eleonore Herquelot, Ludovic Lamarsalle, Fanny Raguideau
Journal: Blood
Blood (2019) 134 (Supplement_1): 2167.
https://doi.org/10.1182/blood-2019-131721
Published: 2019